Spots Global Cancer Trial Database for The Neurofibromatosis-associated Tumor Biobank

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: The Neurofibromatosis-associated Tumor Biobank

Official Title: Establishment of Neurofibromatosis-associated Tumours Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction

Study ID: NCT03359304

Conditions

Neurofibromatoses

Interventions

Study Description

Brief Summary: Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research

Detailed Description: Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material. Questionnaire information, including health history, growth and development, physical activity and family medical history information. If patients have been diagnosed with a neurofibromatosis-associated tumor or another condition the investigator is interested in， the investigator will ask the patient to release medical record information relating to diagnosis and treatment of neurofibromatosis-associated tumor, other cancers, blood disorders, and similar conditions.